Results 191 to 200 of about 738,282 (345)

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1990
M. Brockhaus   +5 more
semanticscholar   +1 more source

Delivery of Multifunctional Microspheres via Intravesical Instillation for Bladder Carcinoma: Therapeutic Potential and Mechanistic Insights

open access: yesAdvanced Healthcare Materials, EarlyView.
PCTM microspheres were successfully synthesized using microfluidic and click chemistry techniques.In Vivo and in vitro experiments have shown that PCTM microspheres have obvious targeting, adhesion, membrane penetration and anti‐tumor properties for bladder tumors.The antitumor mechanism of PCTM microspheres is to indirectly induce S‐stage blockage of ...
Zhaoxiang Lu   +4 more
wiley   +1 more source

Ambiguous Role of p53 in Transcription-Dependent Tumor Cell Death. [PDF]

open access: yesInt J Mol Sci
Romanova AA   +6 more
europepmc   +1 more source

Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients

open access: yes, 2001
J. Crespo   +7 more
semanticscholar   +1 more source

Tumor necrosis factor-α signaling in macrophages.

open access: yesCritical Reviews in Eukaryotic Gene Expression, 2010
N. Parameswaran, S. Patial
semanticscholar   +1 more source

Microneedle Technology in Psoriasis Management: Mechanistic Insights, Technological Innovation, Clinical Progress, and Challenges

open access: yesAdvanced Healthcare Materials, EarlyView.
This review explores the evolving role of microneedle systems in psoriasis management, highlighting their potential for enhanced drug delivery, diagnosis, and disease monitoring. It also discusses unmet clinical needs for psoriasis management and technical challenges, while outlining strategic directions to advance microneedle integration into routine ...
Fatma Moawad   +3 more
wiley   +1 more source

Research progress on recombinant NDV in cancer therapy. [PDF]

open access: yesFront Immunol
Sun J, Wang J, Xiao M, Chen L, Guan Y.
europepmc   +1 more source

siRNA Delivery via Cross‐Linked Gelatin Microparticles Enables Targeted Modulation of Osteogenic‐Vascular Cross‐Talk: An Advanced Human 3D in Vitro Test System for Therapeutic siRNA

open access: yesAdvanced Healthcare Materials, EarlyView.
Osteogenic‐angiogenic cross‐talk is a vital prerequisite for vascularized bone regeneration. In this study, we investigated the effects of siRNA‐mediated silencing of two inhibitory proteins, Chordin and WWP‐1, via CaP‐NP‐loaded gelatin microparticles in osteogenically differentiated microtissues.
Franziska Mitrach   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy